Signatera Residual Disease (MRD) | |
---|---|
|
|
Soft Order Code: NSGN2
|
|
Synonyms: |
|
Container: 2-10 mL Streck tubes
|
|
Normal Volume: 20 mL whole blood
|
|
Minimum Volume: 10 mL whole blood
|
|
Offsite Collection: Collect specimen in Streck tubes in the kit (may or may not have kit), provided to the patient by the clinic for their arrival in blood draw. Send the entire kit to Specimen Processing ambient (including the test requisition and the shipping airbill in the kit)
|
|
Onsite Collection (Michigan Medicine Hospitals Only): Collect specimen in Streck tubes in the kit (may or may not have a kit), provided to the patient by the clinic for their arrival in blood draw. Send the entire kit to Specimen Processing ambient (including the test requisition and the shipping airbill in the kit)
|
|
Days Set Up: Monday - Friday
|
|
Analytic Time: 7 - 10 days
|
|
Reference Range: *Reference ranges may change over time. Please refer to the original patient report when evaluating results.
Interpretive report provided
|
|
Test Usage: Signatera™ is a personalized, tumor-informed assay optimized to detect circulating tumor DNA (ctDNA) for molecular residual disease (MRD) assessment, treatment response monitoring, and early recurrence monitoring.
|
|
Test Methodology: ctDNA Detection
|
|
Additional Information: Test performed by Natera Laboratories
|
|
Storage Temperature: Ambient
|
|
Test ID: 5956
|